Lanxess (LXS) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
6 Nov, 2025Executive summary
Q3 2025 sales declined 16.3% year-over-year to €1,338 million, driven by weak demand, negative currency effects, and portfolio changes, including the Urethane Systems divestment.
EBITDA pre exceptionals fell 27.7% to €125 million, with margin dropping to 9.3% from 10.8%.
Net income was negative at €77 million, compared to €1 million in Q3 2024; adjusted EPS was minus €0.07 versus €0.86 prior year.
Persistently challenging market conditions, especially in agrochemical and construction sectors, impacted performance.
Self-help measures, including cost-saving initiatives and a €100 million cost reduction program, partially offset declines.
Financial highlights
Gross profit decreased 27.2% year-over-year to €254 million.
Operating result (EBIT) was negative €28 million, down from €24 million in Q3 2024.
Cash flow from operating activities was €50 million, down 15.3% year-over-year.
Free cash flow for the first nine months was minus €94 million, compared to minus €18 million prior year.
Net financial liabilities reduced to €2,072 million from €2,381 million at year-end 2024; equity ratio improved to 48%.
Outlook and guidance
Full-year 2025 EBITDA pre exceptionals expected at the lower end of €520–580 million range, reflecting weak demand and seasonal Q4 softness.
No further bonus provision releases expected in Q4; guidance incorporates current business trends.
Persistent macroeconomic uncertainties and excess Asian capacity remain key challenges.
German government stimulus expected to benefit relevant business units from 2026, especially in construction-related segments.
Latest events from Lanxess
- Earnings rose, costs fell, and sustainability advanced amid global uncertainty and strategic refocus.LXS
AGM 20253 Feb 2026 - Q2 2024 EBITDA pre exceptionals surged 69% year-over-year despite lower sales.LXS
Q2 20241 Feb 2026 - EBITDA pre exceptionals jumped 45% and net income returned to profit in Q3 2024.LXS
Q3 202416 Jan 2026 - EBITDA rose 20% in 2024 as cost savings and portfolio focus drove profitability gains.LXS
Q4 202426 Dec 2025 - Q2 sales and EBITDA fell on weak demand, but net debt dropped after Urethane divestment.LXS
Q2 202523 Nov 2025 - EBITDA pre up 32% to €133m; guidance held as Urethane sale supports debt reduction.LXS
Q1 202517 Nov 2025 - EBITDA pre exceptionals rose 32% in Q1 2025, with guidance confirmed at €600–650 million.LXS
Q1 2025(Media)17 Nov 2025 - Phased exit of JV stake begins, unlocking over €1.2bn in value with EBITDA-linked upside.LXS
Investor Update16 Oct 2025